Skip to content

4Accepted Oct 16, 5:00 PM ET

MapLight Therapeutics, Inc.: General counsel Hanson Kristopher sold 9,020 shares

MPLTMapLight Therapeutics, Inc.

Accepted (ET)

5:00 PM

Oct 16, 2026

Filed

Oct 16, 2026

Documents

1

Size

5.9 KB

Summary

MapLight Therapeutics, Inc.: General counsel Hanson Kristopher sold 9,020 shares

Updated

What happened

  • The Form 4 reports that Hanson Kristopher, general counsel, sold 9,020 shares on Oct 15, 2026, at a weighted average price of $8.08 for total proceeds of $72,882.

Key details

  • Transaction date and price: Oct 15, 2026; sale (code S); weighted average price reported $8.08; individual sale prices ranged from $7.755 to $8.3732.
  • Shares owned after the transaction: the filing does not report the number of shares owned after the transaction.
  • Footnotes: F1 states the shares sold were required to be sold to cover statutory tax withholding obligations on vesting restricted stock units and do not represent a discretionary sale by the reporting person. F2 explains the $8.08 is a weighted average and the reporting person will provide a breakdown of shares sold at each price on request.
  • Filing date: filed with the SEC on Oct 16, 2026.

Why it may matter

  • The filing indicates the sale was to satisfy tax withholding on vested restricted stock units rather than an independent discretionary sale.
  • A filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing